SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-135706
Filing Date
2020-12-15
Accepted
2020-12-15 15:34:31
Documents
9
Period of Report
2020-12-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2038483d1_8k.htm 8-K 52486
2 EXHIBIT 2.1 tm2038483d1_ex2-1.htm EX-2.1 744547
3 EXHIBIT 10.1 tm2038483d1_ex10-1.htm EX-10.1 96827
4 EXHIBIT 10.2 tm2038483d1_ex10-2.htm EX-10.2 97130
5 EXHIBIT 10.3 tm2038483d1_ex10-3.htm EX-10.3 24803
6 EXHIBIT 10.4 tm2038483d1_ex10-4.htm EX-10.4 53766
7 EXHIBIT 10.5 tm2038483d1_ex10-5.htm EX-10.5 60360
8 EXHIBIT 99.1 tm2038483d1_ex99-1.htm EX-99.1 24155
9 GRAPHIC image_001.jpg GRAPHIC 5052
  Complete submission text file 0001104659-20-135706.txt   1162440
Mailing Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401
Business Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401 972-2-5486555
Anchiano Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38807 | Film No.: 201389505
SIC: 2834 Pharmaceutical Preparations